Stockreport

Summit Therapeutics up 17% premarket on positive ridinilazole data in CDI patients [Seeking Alpha]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF Summit Therapeutics up 17% premarket on positive ridinilazole data in CDI patients Summit Therapeutics (NASDAQ: SMMT 17% announcing C. difficile The trial evaluated ridi [Read more]